| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.04 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |